AFP and hepatocellular carcinoma: Clinical parameters such as older than 55 years, negative IL36 expression, and AFP ≥400 μg/L predicted poor prognosis; IL36 level were the highest one in HCC patients compared with healthy and hepatitis B patients, which suggested that IL36 could be a novel biomarker for detection of HCC.